# Ertugliflozin for Functional Mitral Regurgitation

Study · id `cardio:ct-nct04231331` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04231331](<https://clinicaltrials.gov/study/NCT04231331>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04231331

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

## Technical summary

Registry record NCT04231331. Randomized; quadruple masking; primary purpose treatment. Start 2020-11-04 (actual); primary completion 2023-11-15 (actual). Results posted on 2025-01-06.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 128 participants (enrolled count; ClinicalTrials.gov record NCT04231331, source copy `cardio:ctgov-nct04231331-2025-01-06`, retrieved 2026-10-26)
- Started: 2020-11-04 (actual) (ClinicalTrials.gov record NCT04231331, source copy `cardio:ctgov-nct04231331-2025-01-06`, retrieved 2026-10-26)
- Primary completion: 2023-11-15 (actual) (ClinicalTrials.gov record NCT04231331, source copy `cardio:ctgov-nct04231331-2025-01-06`, retrieved 2026-10-26)
- Completion: 2023-11-15 (actual) (ClinicalTrials.gov record NCT04231331, source copy `cardio:ctgov-nct04231331-2025-01-06`, retrieved 2026-10-26)
- Results first posted: 2025-01-06 (ClinicalTrials.gov record NCT04231331, source copy `cardio:ctgov-nct04231331-2025-01-06`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04231331, source copy `cardio:ctgov-nct04231331-2025-01-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04231331-2025-01-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ertugliflozin for Functional Mitral Regurgitation
- Acronym: EFFORT
- Condition: Mitral Valve Insufficiency
- Condition: Left Ventricular Systolic Dysfunction
- Intervention (Drug): Ertugliflozin
- Intervention (Drug): Placebo
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER
- Collaborator: Merck Sharp & Dohme LLC
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)
- Registry lists this organization as a collaborator: Merck Sharp & Dohme LLC (`cardio:org-merck-sharp-dohme-llc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial (`cardio:pubmed-38690659`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: de009f5cdeefb5e4f3343400be1e3eeb8952ce1c2477ff9895087bc638116b94
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
